Literature DB >> 30120003

In vitro anti-demodectic effects and terpinen-4-ol content of commercial eyelid cleansers.

Isabella M Y Cheung1, Ally L Xue1, Andy Kim1, Kirsty Ammundsen1, Michael T M Wang1, Jennifer P Craig2.   

Abstract

PURPOSE: To compare the in vitro anti-demodectic activity of four commercially available dedicated eyelid cleansers (Cliradex® towelette cleanser, Oust™ Demodex® cleanser, Blephadex™ eyelid foam, TheraTears® SteriLid® eyelid cleanser), tea tree oil, undiluted terpinen-4-ol and linalool; and to assess the terpinen-4-ol content of the commercial cleansers and tea tree oil.
METHODS: In vitro anti-demodectic efficacy assessment: 93 viable Demodex mites were acquired from the epilated eyelashes of 10 participants, and were randomised to application with one of the four eyelid cleansers, 100% and 50% tea tree oil, undiluted terpinen-4-ol and linalool, or no treatment. Following treatment application, mite viability was assessed for 300 min, based on limb/body movement and/or the development of a crenated/translucent appearance. Kaplan-Meier survival analysis was then performed. MASS SPECTROMETRY ANALYSIS: The absolute concentration of terpinen-4-ol and the relative abundance of linalool in the four eyelid cleansers and tea tree oil were determined.
RESULTS: In vitro anti-demodectic efficacy assessment: No significant differences were observed between undiluted tea tree oil, terpinen-4-ol and linalool (all p > 0.05). Although all commercial eyelid cleansers effected lower mite survival probabilities than the untreated group, Cliradex® was the only eyelid cleanser that demonstrated comparable antiparastic activity to 50% tea tree oil (p = 0.36). MASS SPECTROMETRY ANALYSIS: Among the four eyelid cleansers, Cliradex® contained the highest concentration of terpinen-4-ol, while linalool was present in TheraTears® SteriLid® only.
CONCLUSIONS: Of the four commercial eyelid cleansers, Cliradex® demonstrated the highest levels of in vitro anti-demodectic activity and terpinen-4-ol content. Undiluted linalool and terpenin-4-ol showed comparable antiparasitic efficacy, and the use of linalool in the management of demodectic blepharitis warrants further investigation.
Copyright © 2018 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blepharitis; Demodex; Eyelid cleanser; Eyelid hygiene; Tea tree oil

Mesh:

Substances:

Year:  2018        PMID: 30120003     DOI: 10.1016/j.clae.2018.08.003

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  5 in total

1.  Effects of Terpinen-4-ol on Meibomian Gland Epithelial Cells In Vitro.

Authors:  Di Chen; Jingyi Wang; David A Sullivan; Wendy R Kam; Yang Liu
Journal:  Cornea       Date:  2020-12       Impact factor: 3.152

2.  Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe.

Authors:  Riadh Messaoud; Lamia El Fekih; Anis Mahmoud; Hager Ben Amor; Radhouane Bannour; Serge Doan; Moncef Khairallah
Journal:  Clin Ophthalmol       Date:  2019-06-20

Review 3.  Recent Evidence of Tea Tree Oil Effectiveness in Blepharitis Treatment.

Authors:  Luigi Capasso; Giulia Abbinante; Alessia Coppola; Giulio Salerno; Maddalena De Bernardo
Journal:  Biomed Res Int       Date:  2022-07-30       Impact factor: 3.246

Review 4.  Antiparasitic Activity of Tea Tree Oil (TTO) and Its Components against Medically Important Ectoparasites: A Systematic Review.

Authors:  Solomon Abrha Bezabh; Wubshet Tesfaye; Julia K Christenson; Christine F Carson; Jackson Thomas
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

5.  Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis.

Authors:  Young Choi; Youngsub Eom; Eun Gyu Yoon; Jong Suk Song; Il-Hwan Kim; Hyo Myung Kim
Journal:  Cornea       Date:  2022-04-01       Impact factor: 2.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.